Leibniz Research Alliance INFECTIONS in an Urbanizing World - Humans, Animals, Environments
Improved hygiene and better prevention and treatment have diminished the incidence of infectious diseases particularly in industrialised countries. However, increasing antibiotic resistance, emergence of new pathogens, together with changes in pathogen distribution due to altered climate and mobility are global challenges for humankind. The Leibniz Research Alliance (LRA) INFECTIONS aims to establish an interdisciplinary research agenda and opens up new avenues of communication across disciplines. New strategies and methods for early warning and outbreak management systems will be developed to control spread of pathogens.
NEWS
New Leibniz ScienceCampus for the DSMZ in Braunschweig
The Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures GmbH in Braunschweig, a partner of LFV INFECTIONS, has been leading the new Ecopath ScienceCampus since the spring of this year. The aim of the network is to use systematic approaches to obtain more information about the spread and resistance of zoonosis-causing pathogens and thus learn more about their evolutionary ecology.
8th Plenary Assembly of the Leibniz Research Alliance INFECTIONS at the Bernhard Nocht Institute for Tropical Medicine in Hamburg
From 28 to 30 October 2024, the members of the Leibniz Research Alliance INFECTIONS met for the 8th Plenary Assembly at the Bernhard Nocht Institute for Tropical Medicine (BNITM) in Hamburg. They discussed the future direction of the network and presented their research findings on combating antimicrobial resistance (AMR) - a key issue for global health.
Air in livestock barns - a danger for animals and humans?
In the seed money project AirBarn, aerosols inside and from animal barns are investigated as a potential source for airborne pathogens. It is known that the use of antibiotics in agriculture often selects antibiotic-resistant bacteria, but the extent to which environmental influences can change the composition of bacteria in bioaerosols and where risks arise for humans and the environment are still open research questions.
